Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | VRTX | GILD | BMY |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 242.70 | 265.46 | 468.07 | 91.88 | 56.09 |
| High | 249.58 | 270.26 | 474.18 | 93.59 | 57.77 |
| Low | 240.42 | 264.81 | 465.62 | 91.88 | 56.05 |
| Last | 246.58 | 265.95 | 469.24 | 92.80 | 57.65 |
| Change | +2.59 | -0.55 | +1.15 | +0.75 | +1.78 |
| % Change | +1.06% | -0.21% | +0.25% | +0.81% | +3.19% |
| Volume | 634,400 | 4,742,500 | 1,304,800 | 6,125,600 | 14,984,400 |
| 20-Day Average Volume | 641,125 | 4,611,615 | 1,279,885 | 6,542,185 | 9,712,825 |
| Previous Close | 243.99 | 266.50 | 468.09 | 92.05 | 55.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 249.94 | 278.74 | 462.37 | 91.56 | 58.17 |
| 20-Day Raw Stochastic | 57.08% | 20.62% | 77.06% | 78.41% | 46.28% |
| 20-Day Relative Strength | 42.21% | 30.60% | 49.75% | 56.39% | 53.88% |
| Weighted Alpha | +8.34 | -13.37 | +12.58 | +25.73 | +18.84 |
| Today's Opinion | 8% Sell | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 40% Buy | 40% Sell | 16% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.89% since 12/10/24 | -3.55% since 12/10/24 | unch since 12/10/24 | +0.50% since 12/10/24 | -0.81% since 12/10/24 |
| Low | 240.42 on 12/17/24 | 264.81 on 12/17/24 | 459.79 on 12/13/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 255.92 on 12/11/24 | 276.28 on 12/11/24 | 474.18 on 12/17/24 | 94.65 on 12/11/24 | 58.05 on 12/11/24 |
| 1-Month | |||||
| %Chg | +4.68% since 11/15/24 | -6.23% since 11/15/24 | +0.76% since 11/15/24 | +4.98% since 11/15/24 | +2.54% since 11/15/24 |
| Low | 229.85 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 55.04 on 12/13/24 |
| High | 258.12 on 12/09/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | -10.16% since 09/17/24 | -20.09% since 09/17/24 | -2.50% since 09/17/24 | +11.74% since 09/17/24 | +16.49% since 09/17/24 |
| Low | 229.85 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 81.83 on 09/26/24 | 48.78 on 09/18/24 |
| High | 304.39 on 10/17/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +56.76% since 06/17/24 | -12.31% since 06/17/24 | -0.94% since 06/17/24 | +44.39% since 06/17/24 | +40.71% since 06/17/24 |
| Low | 152.30 on 06/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 304.39 on 10/17/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 31,470,076 | 143,252,544 | 120,546,736 | 114,718,792 | 113,314,248 |
| Shares Outstanding, K | 128,981 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 500,920,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -111,570,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.32 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 10/31/24 | 02/04/25 | 02/03/25 | 02/04/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.08 | 0.00 | 20.73 | 47.68 |